Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Eris Lifesciences Limited (NSE: ERIS), ISIN INE406M01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ERIS last traded at ₹1269.85 (-0.10%), with a 52-week range of ₹1237.90 to ₹1737.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 54.14%, FIIs 5.75%, DIIs 20.72%, mutual funds 18.88%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.